OCM™ Wound Matrix
MULTIMODAL THERAPY FOR ALL PHASES OF WOUND HEALING
OCM™ is the first of its kind, drug-device combination that delivers comprehensive and personalized therapy.
What is OCM™?
OCM™ is a novel, proprietary technology designed to provide personalized wound healing.
OCM™ is an anhydrous conformable sheet that contains cold water-fish peptides and other non-cytoxic components known to be antimicrobial
- OCM™ is a sterile single use drug/device product that is absorbable and biodegradable over time
- OCM™ covers the entire wound, providing a physical barrier and protective environment to support the healing process
INTRODUCING OCM™
OCM™ wound matrix is a novel, proprietary technology focused on comprehensive wound healing. Developed to address the issues common to chronic wounds.
Comprehensive technology
OCM™ wound matrix provides pharmaceutical grade time-released elements that migrate into the tunnels and crevices of the wound bed to support each stage of wound healing.
- Decrease Inflammation
- Increase Proliferation
- Support Remodeling
- Reduce Biofilm Impact
How is OCM™ SUPPLIED?
Description OCM™Pouch (contains single dose package & IFU)
UDI Number 859839007014
Further Information Not commercially available
Description OCM™4-pk carton (contains 4 pouches)
UDI Number 859839007038
Further Information For commercial sale
Description OCM™10-pk carton (contains 4 pouches)
UDI Number 859839007212
Further Information For commercial sale
U.S. Reimbursement Coding information:
CMS (Centers for Medicare & Medicaid Services) coding:
- OCM™ CMS code: A2014
Veterans Administration Federal Supply Schedule:
- OCM™ is available through Marathon Medical, a prime vendor on the Veterans Affairs Federal Supply Schedule (FSS) Service.
- The FSS Contract Number for Marathon Medical is 36F79718D0321.
OCM™ wound matrix is a first of it’s kind, drug-device combination product that provides comprehensive therapy for all phases of wound healing; reduces biofilm formation, reduce inflammation, increase proliferation and support remodeling. OCM™ is delivered in single use, disposable vials.
Healthcare Professionals
We know the challenges of chronic wounds. We’ve been studying them for decades.
- Edema
- Biofilm
- Poor perfusion
We recognize your frustrations.
- Patients regressing and not healing
- 30-day waiting period for access to advanced treatment
- Products that don’t work with real-world patients
Omeza is working to transform the episode of care model for chronic wound care so you can:
- Improve your outcomes
- Reduce your costs
- See more patients
It’s time to stop the cycle of amputations and begin the cycle of healing.
Evidence: Efficacy of OCM™ WOUND CARE MATRIX
Case studies:
Warning: the case studies contain graphic images of wounds.
Professional Poster Presentations of Case Studies Using OCM™
The following posters and abstracts have been submitted to and selected by wound experts for presentation at the Symposium on Advanced Wound Care (SAWC). The submissions are double-blind peer-reviewed by at least 2, and typically 3 referees who are experts in the field of wound care and related specialties. Abstracts are accepted on a competitive basis and in some cases are selected for grand rounds presentation at SAWC. SAWC is sponsored by the Wound Care Learning Network of HMP Global.
For more information about our clinical trials, contact us or visit clinicaltrials.gov
- Diabetic burn
- Diabetic foot ulcer
- Diabetic foot ulcer with charcot
- Sickle cell ulcer
- Venous leg ulcer
Warning: the case studies contain graphic images of wounds.
Professional Poster Presentations of Case Studies Using OCM™
The following posters and abstracts have been submitted to and selected by wound experts for presentation at the Symposium on Advanced Wound Care (SAWC). The submissions are double-blind peer-reviewed by at least 2, and typically 3 referees who are experts in the field of wound care and related specialties. Abstracts are accepted on a competitive basis and in some cases are selected for grand rounds presentation at SAWC. SAWC is sponsored by the Wound Care Learning Network of HMP Global.
- SAWC 2019 biofilm study poster – University of Florida
- SAWC Fall 2021 Sickle Cell study poster – Dr. Jacob Reinkraut
- SAWC Fall 2021 venous leg ulcer poster – Dr. Jacob Reinkraut
- SAWC Spring 2022 Grand Rounds Poster – Dr. Windy Cole
- SAWC Fall 2022 Grand Rounds Poster – Dr. Carmen Hudson
For more information about our clinical trials, contact us or visit clinicaltrials.gov
Peer-Reviewed Publications
Published Manuscripts For OCM™ WOUND CARE MATRIX
Bettle-Jan-2024-Advances in Therapy
Bettle-Jan-2024-Advances in TherapyDownload Swain-Cole-Sept 2024-Journal of Wound Care
Swain-Cole-Sept 2024- Journal of Wound CareDownload Simman-Oct-2024-Journal of Wound Care
Simman-Oct-2024-Journal of Wound CareDownload Reinkraut-Oct-2024-Advances in Skin and Wound Care
Reinkraut-Oct 2024-Advances in Skin and Wound CareDownload Gil-ONLINE-Oct-2024-International Wound Journal
Gil-ONLINE-Oct 2024-International Wound Journal
Bettle-Jan-2024-Advances in TherapyDownload Swain-Cole-Sept 2024-Journal of Wound Care
Swain-Cole-Sept 2024- Journal of Wound CareDownload Simman-Oct-2024-Journal of Wound Care
Simman-Oct-2024-Journal of Wound CareDownload Reinkraut-Oct-2024-Advances in Skin and Wound Care
Reinkraut-Oct 2024-Advances in Skin and Wound CareDownload Gil-ONLINE-Oct-2024-International Wound Journal
Gil-ONLINE-Oct 2024-International Wound Journal
Case Studies
Case studies OF COMPLETE CLOSURE OF A Diabetic Foot Ulcer AND A CHARCOT FOOT ULCER
Diabetic Foot Ulcers –
Case studies Presented at APWCA Wound Week 2023
Trusted by Leading Physicians and Healthcare Systems
Our Mission is to be a Resource to our Surgery Centers, Hospitals and Physician Offices By Providing The Best Possible Savings With Best In Class Solutions.